ATE308557T1 - Antipicornavirale verbindungen, deren herstellung und verwendung - Google Patents
Antipicornavirale verbindungen, deren herstellung und verwendungInfo
- Publication number
- ATE308557T1 ATE308557T1 AT03009409T AT03009409T ATE308557T1 AT E308557 T1 ATE308557 T1 AT E308557T1 AT 03009409 T AT03009409 T AT 03009409T AT 03009409 T AT03009409 T AT 03009409T AT E308557 T1 ATE308557 T1 AT E308557T1
- Authority
- AT
- Austria
- Prior art keywords
- production
- antipicornaviral compounds
- antipicornaviral
- compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/24—Oxygen or sulfur atoms
- C07D207/26—2-Pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
- C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
- C07D261/10—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D261/18—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
- C07K5/0205—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-(X)3-C(=0)-, e.g. statine or derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US8382898P | 1998-04-30 | 1998-04-30 | |
| US9835898P | 1998-08-28 | 1998-08-28 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE308557T1 true ATE308557T1 (de) | 2005-11-15 |
Family
ID=26769788
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT03009409T ATE308557T1 (de) | 1998-04-30 | 1999-01-05 | Antipicornavirale verbindungen, deren herstellung und verwendung |
| AT99900780T ATE248186T1 (de) | 1998-04-30 | 1999-01-05 | Antipicornavirale verbindungen, deren herstellung und verwendung |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT99900780T ATE248186T1 (de) | 1998-04-30 | 1999-01-05 | Antipicornavirale verbindungen, deren herstellung und verwendung |
Country Status (34)
| Country | Link |
|---|---|
| US (3) | US6531452B1 (de) |
| EP (1) | EP1073672B1 (de) |
| JP (1) | JP2003526600A (de) |
| KR (1) | KR20010043004A (de) |
| CN (1) | CN1198838C (de) |
| AP (1) | AP2000001934A0 (de) |
| AT (2) | ATE308557T1 (de) |
| AU (1) | AU768539B2 (de) |
| BG (1) | BG104899A (de) |
| BR (1) | BR9910573A (de) |
| CA (1) | CA2326763A1 (de) |
| DE (2) | DE69910762T2 (de) |
| DK (1) | DK1073672T3 (de) |
| EA (1) | EA003856B1 (de) |
| EE (1) | EE200000621A (de) |
| ES (1) | ES2205760T3 (de) |
| GE (1) | GEP20022824B (de) |
| HK (1) | HK1034722A1 (de) |
| HR (1) | HRP20000623A2 (de) |
| HU (1) | HUP0400624A2 (de) |
| IL (1) | IL138609A0 (de) |
| IS (1) | IS5633A (de) |
| LT (1) | LT4846B (de) |
| LV (1) | LV12666B (de) |
| NO (1) | NO20005411L (de) |
| NZ (1) | NZ507633A (de) |
| OA (1) | OA11503A (de) |
| PL (1) | PL351250A1 (de) |
| PT (1) | PT1073672E (de) |
| SI (1) | SI20428A (de) |
| SK (1) | SK284714B6 (de) |
| TR (1) | TR200003159T2 (de) |
| WO (1) | WO1999057135A1 (de) |
| YU (1) | YU66000A (de) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HUP0400624A2 (hu) | 1998-04-30 | 2004-06-28 | Agouron Pharmaceuticals, Inc. | Picornavírus-ellenes vegyületek, előállításuk és alkalmazásuk |
| US6774243B2 (en) | 1999-08-24 | 2004-08-10 | Agouron Pharmaceuticals, Inc. | Efficient synthetic routes for the preparation of rhinovirus protease inhibitors and key intermediates |
| PE20010517A1 (es) * | 1999-08-24 | 2001-05-16 | Agouron Pharma | Las rutas sinteticas eficientes para la preparacion de los inhibidores de la proteasa del rinovirus y los intermedios claves |
| US6355807B1 (en) | 1999-08-24 | 2002-03-12 | Agouron Pharmaceuticals, Inc. | Efficient synthetic routes for the preparation of rhinovirus protease inhibitors and key intermediates |
| PA8507801A1 (es) | 1999-12-03 | 2002-08-26 | Agouron Pharma | Compuestos y composiciones antipicornavirales, sus usos farmaceuticos y los materiales para su sintesis |
| PE20011277A1 (es) | 2000-04-14 | 2002-01-07 | Agouron Pharma | Compuestos y composiciones antipicornavirales, sus usos farmaceuticos y los materiales para su sintesis |
| MXPA02012456A (es) * | 2000-06-14 | 2004-01-26 | Agouron Pharma | Compuestos y composiciones antipicornavirales, sus usos farmaceuticos y materiales para su sintesis. |
| WO2004093860A1 (en) * | 2003-04-21 | 2004-11-04 | Pfizer Inc. | Inhibitors of sars related coronavirus proteinase |
| US20040235952A1 (en) * | 2003-05-05 | 2004-11-25 | Agouron Pharmaceuticals, Inc. | Inhibitors of severe acute respiratory syndrome (SARS) 3C-like proteinase |
| US7462594B2 (en) | 2003-12-31 | 2008-12-09 | Taigen Biotechnology Co., Ltd. | Peptide-like compounds that inhibit coronaviral 3CL and flaviviridae viral proteases |
| AU2004312547A1 (en) * | 2003-12-31 | 2005-07-21 | Taigen Biotechnology | Protease inhibitors |
| CN100363346C (zh) * | 2004-10-22 | 2008-01-23 | 清华大学 | 冠状病毒主蛋白酶的小分子抑制剂、制备方法及其应用 |
| US7893657B2 (en) * | 2006-12-19 | 2011-02-22 | Anand Kumar Chavakula | Multi-power charger and battery backup system |
| KR100891699B1 (ko) | 2007-04-10 | 2009-04-03 | 광주과학기술원 | 7-아미노-4-((ｓ)-3-(4-플루오로페닐)-2-((r)-3-메틸-2-(5-메틸이소옥사졸-3-카복사미도)부탄아미도)프로판아미도)-7-옥소-2-헵테노에이트 유도체, 이의 제조방법 및 이를 유효성분으로 함유하는 바이러스성 질환의 예방 및 치료용 약학적 조성물 |
| US7741327B2 (en) | 2008-04-16 | 2010-06-22 | Hoffmann-La Roche Inc. | Pyrrolidinone glucokinase activators |
| CN102105485B (zh) | 2008-05-21 | 2016-01-13 | 新世界实验室公司 | 选择性胱天蛋白酶抑制剂及其用途 |
| WO2010133000A1 (en) | 2009-05-21 | 2010-11-25 | New World Laboratories Inc. | Selective caspase inhibitors and uses thereof |
| US8178689B2 (en) | 2010-06-17 | 2012-05-15 | Hoffman-La Roche Inc. | Tricyclic compounds |
| WO2012140500A1 (en) | 2011-04-15 | 2012-10-18 | New World Laboratories, Inc. | Selective cysteine protease inhibitors and uses thereof |
| CN102838523A (zh) * | 2011-06-23 | 2012-12-26 | 南开大学 | 抗肠病毒71(ev71)戊内酰胺类化合物及其制备方法和用途 |
| CN103145608B (zh) * | 2011-12-07 | 2015-09-02 | 南开大学 | 抗肠病毒71(ev71)己内酰胺类化合物及其制备方法和用途 |
| RU2518314C2 (ru) * | 2012-08-30 | 2014-06-10 | Общество С Ограниченной Ответственностью "Фарминтерпрайсез" | Способ и средство активации irf-3 для лечения и профилактики заболеваний, вызываемых (+) phk-содержащими вирусами |
| CN110105348A (zh) * | 2019-03-08 | 2019-08-09 | 南开大学 | 新型迈克尔受体类肠病毒71型抑制剂的制备及用途 |
| AU2020289560A1 (en) | 2019-06-05 | 2021-12-23 | Emory University | Peptidomimetics for the treatment of coronavirus and picornavirus infections |
| US20230157998A1 (en) | 2020-03-06 | 2023-05-25 | Pfizer Inc. | Methods of Inhibiting SARS-CoV-2 Replication and Treating Corona Virus Disease 2019 |
| CN116648240A (zh) * | 2021-01-22 | 2023-08-25 | 中国人民解放军军事科学院军事医学研究院 | 一种环肽类病毒蛋白酶抑制剂，其制备方法，及其在抗病毒药物中的应用 |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4652676A (en) | 1985-05-06 | 1987-03-24 | General Foods Corporation | L-aminodicarboxylic acid alkenes |
| JPH06510986A (ja) | 1991-06-14 | 1994-12-08 | カイロン コーポレイション | ピコルナウイルスプロテアーゼのインヒビター |
| US5374623A (en) | 1992-08-20 | 1994-12-20 | Prototek, Inc. | Cysteine protease inhibitors effective for in vivo use |
| US5514778A (en) | 1993-07-01 | 1996-05-07 | Eli Lilly And Company | Anti-picornaviral agents |
| US5486623A (en) | 1993-12-08 | 1996-01-23 | Prototek, Inc. | Cysteine protease inhibitors containing heterocyclic leaving groups |
| IL112759A0 (en) | 1994-02-25 | 1995-05-26 | Khepri Pharmaceuticals Inc | Novel cysteine protease inhibitors |
| IT1269511B (it) | 1994-05-17 | 1997-04-01 | Univ Degli Studi Milano | Derivati di acidi ammino-solfonici , loro impiego nella sintesi di pseudopeptidi e procedimento per la loro preparazione |
| US5498616A (en) * | 1994-11-04 | 1996-03-12 | Cephalon, Inc. | Cysteine protease and serine protease inhibitors |
| IT1281031B1 (it) | 1995-11-17 | 1998-02-11 | Carlo Chiaves | Struttura prefabbricata per la realizzazione di opere costruite a cielo aperto, particolarmente per cavalcavia autostradali, |
| IL120310A (en) | 1996-03-01 | 2002-02-10 | Akzo Nobel Nv | Serine protease inhibitors and pharmaceuticals containing them |
| US5856530A (en) | 1996-05-14 | 1999-01-05 | Agouron Pharmaceuticals, Inc. | Antipicornaviral compounds and methods for their use and preparation |
| ES2242225T3 (es) * | 1996-05-14 | 2005-11-01 | Agouron Pharmaceuticals, Inc. | Inhibidores de proteasas 3c antipicornavirales y procedimientos correspondientes de utilizacion y de preparacion. |
| WO1997049668A1 (en) | 1996-06-13 | 1997-12-31 | Smithkline Beecham Corporation | Inhibitiors of cysteine protease |
| US6020371A (en) | 1997-03-28 | 2000-02-01 | Agouron Pharmaceuticals, Inc. | Antipicornaviral compounds compositions containing them and methods for their use |
| PT975588E (pt) * | 1997-03-28 | 2004-02-27 | Agouron Pharma | Compostos antipicornavirais, composicoes que os contem e metodos para a sua utilizacao |
| US6331554B1 (en) * | 1997-03-28 | 2001-12-18 | Agouron Pharmaceuticals, Inc. | Antipicornaviral compounds, compositions containing them, and methods for their use |
| US5962487A (en) | 1997-12-16 | 1999-10-05 | Agouron Pharmaceuticals, Inc. | Antipicornaviral compounds and methods for their use and preparation |
| HUP0400624A2 (hu) | 1998-04-30 | 2004-06-28 | Agouron Pharmaceuticals, Inc. | Picornavírus-ellenes vegyületek, előállításuk és alkalmazásuk |
| US6369226B1 (en) | 1999-06-21 | 2002-04-09 | Agouron Pharmaceuticals, Inc. | Substituted benzamide inhibitors of rhinovirus 3C protease |
| CN1372566A (zh) | 1999-08-04 | 2002-10-02 | 阿格罗尼制药公司 | 抗细小核糖核酸病毒的化合物和组合物,它们的药物用途,及其合成原料 |
| PE20010517A1 (es) | 1999-08-24 | 2001-05-16 | Agouron Pharma | Las rutas sinteticas eficientes para la preparacion de los inhibidores de la proteasa del rinovirus y los intermedios claves |
| EP1206470A2 (de) | 1999-08-24 | 2002-05-22 | Agouron Pharmaceuticals, Inc. | Verfahren und zwischenprodukte zur herstellung von isoxazolcarboxamiden und analogen |
| PA8507801A1 (es) | 1999-12-03 | 2002-08-26 | Agouron Pharma | Compuestos y composiciones antipicornavirales, sus usos farmaceuticos y los materiales para su sintesis |
-
1999
- 1999-01-05 HU HU0400624A patent/HUP0400624A2/hu unknown
- 1999-01-05 CN CNB998056278A patent/CN1198838C/zh not_active Expired - Fee Related
- 1999-01-05 EP EP99900780A patent/EP1073672B1/de not_active Expired - Lifetime
- 1999-01-05 AU AU20287/99A patent/AU768539B2/en not_active Ceased
- 1999-01-05 DK DK99900780T patent/DK1073672T3/da active
- 1999-01-05 LT LT2000109A patent/LT4846B/lt not_active IP Right Cessation
- 1999-01-05 AT AT03009409T patent/ATE308557T1/de not_active IP Right Cessation
- 1999-01-05 EE EEP200000621A patent/EE200000621A/xx unknown
- 1999-01-05 DE DE69910762T patent/DE69910762T2/de not_active Expired - Fee Related
- 1999-01-05 SI SI9920041A patent/SI20428A/sl not_active IP Right Cessation
- 1999-01-05 NZ NZ507633A patent/NZ507633A/en unknown
- 1999-01-05 EA EA200001133A patent/EA003856B1/ru not_active IP Right Cessation
- 1999-01-05 TR TR2000/03159T patent/TR200003159T2/xx unknown
- 1999-01-05 YU YU66000A patent/YU66000A/sh unknown
- 1999-01-05 SK SK1604-2000A patent/SK284714B6/sk unknown
- 1999-01-05 JP JP2000547104A patent/JP2003526600A/ja not_active Withdrawn
- 1999-01-05 PT PT99900780T patent/PT1073672E/pt unknown
- 1999-01-05 AP APAP/P/2000/001934A patent/AP2000001934A0/en unknown
- 1999-01-05 PL PL99351250A patent/PL351250A1/xx not_active Application Discontinuation
- 1999-01-05 BR BR9910573-0A patent/BR9910573A/pt not_active IP Right Cessation
- 1999-01-05 KR KR1020007011851A patent/KR20010043004A/ko not_active Application Discontinuation
- 1999-01-05 WO PCT/US1999/000260 patent/WO1999057135A1/en not_active Application Discontinuation
- 1999-01-05 AT AT99900780T patent/ATE248186T1/de not_active IP Right Cessation
- 1999-01-05 IL IL13860999A patent/IL138609A0/xx unknown
- 1999-01-05 CA CA002326763A patent/CA2326763A1/en not_active Abandoned
- 1999-01-05 ES ES99900780T patent/ES2205760T3/es not_active Expired - Lifetime
- 1999-01-05 DE DE69928140T patent/DE69928140D1/de not_active Expired - Lifetime
- 1999-01-05 GE GEAP19995606A patent/GEP20022824B/en unknown
- 1999-04-29 US US09/301,977 patent/US6531452B1/en not_active Expired - Fee Related
-
2000
- 2000-09-20 HR HR20000623A patent/HRP20000623A2/hr not_active Application Discontinuation
- 2000-09-22 IS IS5633A patent/IS5633A/is unknown
- 2000-10-20 OA OA1200000288A patent/OA11503A/en unknown
- 2000-10-27 NO NO20005411A patent/NO20005411L/no not_active Application Discontinuation
- 2000-11-01 BG BG104899A patent/BG104899A/xx unknown
- 2000-12-19 LV LV000162A patent/LV12666B/xx unknown
-
2001
- 2001-08-06 HK HK01105452A patent/HK1034722A1/xx not_active IP Right Cessation
-
2002
- 2002-11-06 US US10/289,982 patent/US6995142B2/en not_active Expired - Fee Related
-
2005
- 2005-08-24 US US11/210,717 patent/US20060046966A1/en not_active Abandoned
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69910762D1 (de) | Antipicornavirale verbindungen, deren herstellung und verwendung | |
| ATE302604T1 (de) | Thienylazolylalkoxyethanamine, deren herstellung und deren verwendung als medikamente | |
| ATE284392T1 (de) | Substituierte 2-phenylbenzimidazole, deren herstellung und anwendung | |
| DE60034683D1 (de) | 3(5)-ureido-pyrazolderivate, deren herstellungsverfahren und verwendung als krebshemmende mittel | |
| ATE249460T1 (de) | 1,4-diazabicyclo(3.2.2)nonanderivate, deren herstellung und deren verwendung in heilkunde | |
| DE60008862D1 (de) | Thienopyrimidin verbindungen, ihre herstellung und verwendung | |
| DE60035127D1 (de) | Mit polysacchariden beschichtete träger, deren herstellung und verwendung | |
| ATE286021T1 (de) | Substituierte phenylderivate, ihre herstellung und verwendung | |
| DE60023012D1 (de) | 3(5)-amino-pyrazolderivate, deren herstellungsverfahren und verwendung als krebshemmende mittel | |
| DE69604285T2 (de) | Polysiloxan-polyol makromere, deren herstellung und verwendung | |
| DE69529026T2 (de) | Trehalose, ihre Herstellung und ihre Verwendung | |
| DE69728840D1 (de) | Kojibiose Phosphorylase, deren Herstellung und Verwendung | |
| ATE239693T1 (de) | 3,3-diarylpropylamine , ihre verwendung und herstellung | |
| DE69915693D1 (de) | 2,5-diazabicyclo(2.2.1)heptanderivate, deren herstellung und deren verwendung in heilkunde | |
| DE69901177T2 (de) | Platinkomplex, dessen herstellung und dessen therapeutische verwendung | |
| DE69909345D1 (de) | Phthalocyaninverbindung, deren Herstellungsverfahren und Verwendung | |
| DE59800590D1 (de) | Polymere organosiliciumverbindungen, deren herstellung und verwendung | |
| DE60009155D1 (de) | Substituierte phenyl-piperazin-derivate, deren herstellung und verwendung | |
| DE60008419D1 (de) | Farbstoffpräparate, deren herstellung und deren verwendung | |
| ATE251170T1 (de) | Titanverbindungen, deren herstellung und verwendung | |
| DE59802590D1 (de) | Cyclische Cedren-Acetale, ihre Herstellung und ihre Verwendung | |
| ATE242197T1 (de) | 3-amino-3-arylpropan-1-ol-derivate, deren herstellung und verwendung | |
| DE59900546D1 (de) | Pseudoböhmit und gamma al2o3 enthaltender trägerkatalysator, dessen herstellung und dessen verwendung zur herstellung von 1,2-dichlorethan | |
| DE59802922D1 (de) | 3-substituierte tetrahydropyridopyrimidinon-derivate, ihre herstellung und verwendung | |
| ATE310741T1 (de) | Organozinnkatalysator, herstellung und verwendung |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |